Consulting, Compliance and Validation

Archive for March, 2019

Risk analysis, is it time for a change of mentality?

In Europe, the development of risk analysis in the pharmaceutical sector took its first steps in 1998, as an appendix to the Gamp (Good automated manufacturing practice) guidelines. The fifth revision of the Gamp guidelines clearly states that “the application of quality[…]

Read More

If validation becomes faster and easier, the advantage for the pharmaceutical company is considerable

The long time required for compulsory ministerial validation is a handicap for the pharmaceutical industry, which needs to introduce quickly its product into the market. On the other hand, properly performed validation is necessary to guarantee the integrity and safety of the[…]

Read More